AI Embryo Selection, Explained Plainly

Several leading fertility clinics in Bogotá now use AI-assisted embryo grading as part of standard IVF lab workflow. It's genuinely useful technology — worth understanding clearly, separate from how it's sometimes marketed.

What the technology actually does

Time-lapse incubators equipped with continuous imaging let embryologists watch cell division in real time without removing embryos from stable temperature and pH conditions — something traditional manual grading requires. Machine-learning software then analyzes those images for morphokinetic patterns (the timing and pattern of cell division) that correlate with higher implantation potential.

How it fits alongside PGT testing

AI morphokinetic grading and genetic testing (PGT-A for chromosomal screening, PGT-M for specific genetic disease screening) are complementary, not competing, tools. Morphokinetic data looks at how an embryo develops over time; PGT testing looks directly at its genetic makeup. Used together, they give embryologists a fuller picture when multiple viable embryos are available and a ranking decision needs to be made. Our PGT-A explainer covers the genetic testing side in full.

What it doesn't do

It doesn't guarantee pregnancy, doesn't eliminate the role of a physician's clinical judgment, and doesn't replace a frank conversation with your fertility specialist about your specific case, age, and prior history. Any claim that AI technology alone can predict a specific outcome with high confidence deserves a follow-up question about the actual data behind that claim.

The honest bottom line

This is one of the more genuinely useful applications of AI in medical tourism today — narrow, well-defined, and additive to existing clinical practice rather than replacing it. That's worth knowing both because it's a real reason Bogotá's fertility sector has drawn international attention in 2026, and because it helps you ask better questions in a consultation.